Published Ahead-of-Print - Last Updated: April 27, 2017

The editors of this journal are pleased to offer electronic publication of accepted papers prior to print publication. These papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue.

Disclaimer: Articles appearing in this Published Ahead-of-Print section have been peer-reviewed and accepted for publication in this journal and posted online before print publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Lippincott Williams & Wilkins, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained in the articles in this section.

Published Ahead-of-Print Articles are available in PDF format only.


PDF Only



PDF Only


Exploratory Phase II Trial to Evaluate the Safety and the Antiepileptic Effect of Pitolisant (BF2.649) in Refractory Partial Seizures, Given as Adjunctive Treatment During 3...

Collart Dutilleul, Pierre; Ryvlin, Philippe; Kahane, Philippe; More

Clinical Neuropharmacology ., Post Author Corrections: May 25, 2016

Reduction in the Free Radical Status and Clinical Benefit of Repeated Intrathecal Triamcinolone Acetonide Application in Patients With Progressive Multiple Sclerosis.

Müller, Thomas; Herrling, Thomas; Lütge, Sven; More

Clinical Neuropharmacology ., Post Author Corrections: January 17, 2014

Long-term Safety of Rivastigmine in Parkinson Disease Dementia: An Open-Label, Randomized Study.

Emre, Murat; Poewe, Werner; De Deyn, Peter Paul; More

Clinical Neuropharmacology ., Post Author Corrections: January 17, 2014


PDF Only



PDF Only


1 2 3 4 5